Evidence map›Paper›PMID 32144141›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.

Lindsay A Welikovitch, Sonia Do Carmo, Zsófia Maglóczky, Janice C Malcolm, János Lőke, William L Klein, Tamás Freund, A Claudio Cuello

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. A lifespan staging model of basal forebrain cholinergic vulnerability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Lindsay A WelikovitchDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC H3G 1Y6, Canada.
Sonia Do CarmoDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC H3G 1Y6, Canada.
Zsófia MaglóczkyHuman Brain Research Laboratory, Institute of Experimental Medicine of the Hungarian Academy of Sciences, 1051 Budapest, Hungary.
Janice C MalcolmDepartment of Anatomy and Cell Biology, McGill University, Montreal, QC H3G 1Y6, Canada.
János LőkeDepartment of Psychiatry, Szent Borbála Hospital, 2800 Tatabánya, Hungary.
William L KleinDepartment of Neurobiology, Northwestern University, Evanston, IL 60208.
Tamás FreundLaboratory of Cerebral Cortex Research, Institute of Experimental Medicine of the Hungarian Academy of Sciences, 1051 Budapest, Hungary.
A Claudio CuelloDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC H3G 1Y6, Canada; claudio.cuello@mcgill.ca.
McGill University · CAHungarian Academy of Sciences · HUHUN-REN Institute of Experimental Medicine · HUNorthwestern University · USSzent Borbála Kórház · HUUniversity of Oxford · GB

Funding

CIHR 2017-1.2.1-NKP-2017-00002CIHR PJT-364544
6 · The paper itself

Abstract

Chronic inflammation during Alzheimer's disease (AD) is most often attributed to sustained microglial activation in response to amyloid-β (Aβ) plaque deposits and cell death. However, cytokine release and microgliosis are consistently observed in AD transgenic animal models devoid of such pathologies, bringing into question the underlying processes that may be at play during the earliest AD-related immune response. We propose that this plaque-independent inflammatory reaction originates from neurons burdened with increasing levels of soluble and oligomeric Aβ, which are known to be the most toxic amyloid species within the brain. Laser microdissected neurons extracted from preplaque amyloid precursor protein (APP) transgenic rats were found to produce a variety of potent immune factors, both at the transcript and protein levels. Neuron-derived cytokines correlated with the extent of microglial activation and mobilization, even in the absence of extracellular plaques and cell death. Importantly, we identified an inflammatory profile unique to Aβ-burdened neurons, since neighboring glial cells did not express similar molecules. Moreover, we demonstrate within disease-vulnerable regions of the human brain that a neuron-specific inflammatory response may precede insoluble Aβ plaque and tau tangle formation. Thus, we reveal the Aβ-burdened neuron as a primary proinflammatory agent, implicating the intraneuronal accumulation of Aβ as a significant immunological component in the AD pathogenesis.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloidosisAnimalsBrainDisease Models, AnimalFemaleHumansInflammationMaleNeuronsPlaque, AmyloidRatsRats, TransgenicAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAlzheimer’s diseaseintraneuronal Aβneuronal inflammationpreplaque pathology

Identifiers

PMID32144141
PMCPMC7104377
OpenAlexW3009672833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.